Analysts have significantly upgraded revenue and earnings forecasts for Powerwell Holdings Berhad (KLSE:PWRWELL), leading to a sharp rise in the price target. However, the projected growth rate still lags behind broader industry expectations.
Apple shares edged higher following a robust Q1 earnings report headlined by record iPhone revenue, yet the muted gains reflect Wall Street's growing focus on looming supply constraints and the company's strategic pivot to artificial intelligence.
A dramatic sell-off in precious metals, led by a record-breaking drop in silver, rattled financial markets on January 30, 2026, as a surging U.S. dollar and shifting expectations for Federal Reserve policy triggered a broad retreat from risk assets.
A new IADS report reveals how luxury's slowdown and a permanent shift to casual styles are forcing major retailers to pivot. The response: doubling down on athleisure, accessible price points, and in-store experiences to attract customers and sustain growth.
While outlining stabilization efforts in challenged segments like Fibers, Eastman Chemical's leadership emphasized that a sustained recovery hinges on broader end-market demand. The company is betting on strategic projects and chemical recycling to drive future growth amid persistent pricing pressures and global trade dynamics.
LVMH's recent 0.8% single-day gain to €546.9 offers a glimmer of hope after a period of weaker performance, sparking debate among analysts over whether the market is underestimating the luxury conglomerate's long-term resilience and global footprint.
A Goodyear, Arizona woman's attempt to fix her TV's closed captioning spiraled into a six-month ordeal, culminating in the loss of her life savings. This case highlights the sophisticated tactics of modern fraudsters and a dramatic surge in high-dollar scams targeting older adults.
Cocoa futures have plunged to multi-year lows, pressured by a global surplus and weakening demand as high chocolate prices curb consumption. Analysts point to favorable harvests in West Africa and falling processing volumes as key factors extending the market's month-long decline.
Arabica and robusta coffee futures tumbled this week, pressured by forecasts of beneficial rains in Brazil and a surge in exports from Vietnam. Analysts point to a complex global supply picture as prices retreat from recent highs.
A catastrophic landslide at a major coltan mine in rebel-held eastern Congo has killed hundreds of informal miners, casting a harsh light on the deadly human cost behind the global tech supply chain.
U.S. stocks extended losses into a third session as investors weighed the potential implications of Kevin Warsh's nomination to lead the Federal Reserve, capping a volatile week of trading.
A dual shift in U.S. sanctions and Venezuelan oil law is unlocking the country's vast reserves for American companies, marking a potential turning point after decades of nationalization and economic isolation.
A discounted cash flow analysis suggests Australis Oil & Gas (ASX:ATS) shares may be trading close to their intrinsic value. We examine the model's assumptions and the broader context for the energy junior.
After a November dip, Texas's upstream oil and gas sector added 2,000 jobs in December, contributing to the state's record-breaking employment figures and underscoring the industry's pivotal role in the Texan economy and tax base.
Shares of Heidelberg Materials have delivered stellar returns, more than tripling over three years. As the stock consolidates near recent highs, investors are questioning whether the rally has priced in future growth or if significant value remains. A deep dive into valuation metrics suggests the latter.
Former CNN anchor Don Lemon faces federal charges under the Freedom of Access to Clinic Entrances (FACE) Act after a protest at a Minnesota church, marking a rare application of the law beyond abortion clinic demonstrations and raising First Amendment questions.
Investors face a classic choice between AbbVie's steady dividends and Abivax's high-risk, high-reward potential as both target lucrative immunology markets.
After the COVID-19 windfall subsided, Pfizer CEO Albert Bourla is steering the pharmaceutical giant into a high-stakes, $23 billion pivot to cancer research. Facing a looming patent cliff and plummeting vaccine revenue, Bourla is betting on scientific innovation to secure the company's future—and redefine cancer treatment.
The Producer Price Index jumped 0.5% last month, more than double November's increase, as rising costs for machinery, metals, and travel services pointed to persistent pipeline pressures for consumers.
A week of significant stock swings saw Lockheed Martin and Texas Instruments surge on strong outlooks, while Humana plunged on regulatory headwinds. Here’s what drove the action and what analysts are saying.
